Acne vulgaris. The past. The present and the future.
D000152:Acne Vulgaris / Q000188:drug therapy / Q000209:etiology; D000726:Androgen Antagonists / Q000627:therapeutic use; D000728:Androgens / Q000009:adverse effects; D001585:Benzoyl Peroxide / Q000627:therapeutic use; D003534:Cyproterone / Q000627:therapeutic use; D017373:Cyproterone Acetate; D012628:Dermatitis, Seborrheic / Q000150:complications; D004338:Drug Combinations / Q000627:therapeutic use; D004917:Erythromycin / Q000627:therapeutic use; D004997:Ethinyl Estradiol / Q000627:therapeutic use; D005260:Female; D006801:Humans; D015474:Isotretinoin; D008297:Male; D011425:Propionibacterium acnes / Q000302:isolation & purification; D012629:Sebum / Q000378:metabolism; D013752:Tetracycline / Q000627:therapeutic use; D014212:Tretinoin / Q000627:therapeutic use
D000726:Androgen Antagonists; D000728:Androgens; D004338:Drug Combinations; D004997:Ethinyl Estradiol; D017373:Cyproterone Acetate; D014212:Tretinoin; C032640:Cyproterone acetate, ethinyl estradiol drug combination; D004917:Erythromycin; D003534:Cyproterone; D015474:Isotretinoin; D013752:Tetracycline; D001585:Benzoyl Peroxide